{"id":145782,"date":"2023-05-11T08:40:28","date_gmt":"2023-05-11T12:40:28","guid":{"rendered":"https:\/\/44.250.171.167\/?p=145782"},"modified":"2023-05-11T08:40:29","modified_gmt":"2023-05-11T12:40:29","slug":"orchid-pharma-limited-q4fy23-earnings-story","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/orchid-pharma-limited-q4fy23-earnings-story\/","title":{"rendered":"Orchid Pharma Limited Q4FY23 Earnings Story"},"content":{"rendered":"\n<p>Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Orchid Pharma Ltd. reported Total Income for Q4FY23 of \u20b9 212 Crores up from \u20b9 180 Crore year on year, a rise of 18%.<br><br><\/li><li>Total Expenses for Q4FY23 of \u20b9 185 Crores up from \u20b9 183 Crores year on year, rise of 1%.<br><br>\u00a0<\/li><li>Consolidated Net Profit of \u20b9 59 Crores, up from a loss of \u20b9 7 Crores in the same quarter of the previous year.<br><br>\u00a0<\/li><li>The Earnings per Share is \u20b9 14.49, up from \u20b9 -1.61 in the same quarter of the previous year.<\/li><\/ul>\n\n\n\n<div class=\"wp-block-image is-style-default\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-23.png\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"303\" height=\"402\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-23.png\" alt=\"\" class=\"wp-image-145787\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-23.png 303w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-23-226x300.png 226w\" sizes=\"auto, (max-width: 303px) 100vw, 303px\" \/><\/a><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd. reported Total Income for Q4FY23 of \u20b9 212 Crores up from \u20b9 180 Crore year on year, a rise of [&hellip;]<\/p>\n","protected":false},"author":1885,"featured_media":138549,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5747],"tags":[10162],"class_list":["post-145782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-healthcare-stocks","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":148100,"url":"https:\/\/alphastreet.com\/india\/natco-pharma-q4fy23-earnings-story\/","url_meta":{"origin":145782,"position":0},"title":"Natco Pharma Q4FY23 Earnings Story","author":"Karan_Singh","date":"June 2, 2023","format":false,"excerpt":"NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.\u00a0 Financial Results: Natco Pharma Ltd. reported Total Income for Q4FY23 of \u20b9 2,812 Crores up from \u20b9 2,044 Crore year on year, a rise\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":156573,"url":"https:\/\/alphastreet.com\/india\/orchid-pharma-ltd-q2fy24-21-rise-in-revenue\/","url_meta":{"origin":145782,"position":1},"title":"Orchid Pharma Ltd Q2FY24; 21% rise in Revenue","author":"Hardik Bhandare","date":"November 22, 2023","format":false,"excerpt":"Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd reported Revenues for Q2FY24 of \u20b9199.00 Crores up from \u20b9165.00 Crore year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152674,"url":"https:\/\/alphastreet.com\/india\/orchid-pharma-ltd-q1fy24-40-rise-in-revenue\/","url_meta":{"origin":145782,"position":2},"title":"Orchid Pharma Ltd Q1FY24; 40% rise in Revenue","author":"Karan_Singh","date":"August 10, 2023","format":false,"excerpt":"Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd reported Revenues for Q1FY24 of \u20b9182.92 Crores up from \u20b9130.99 Crore year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":148298,"url":"https:\/\/alphastreet.com\/india\/piramal-pharma-q4fy23-earnings-story\/","url_meta":{"origin":145782,"position":3},"title":"Piramal Pharma Q4FY23 Earnings Story","author":"Karan_Singh","date":"June 2, 2023","format":false,"excerpt":"Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and manufacturing organisations (CDMO), (2) Complex hospital generics (critical care), and (3) consumer healthcare (OTC). Financial Results: Piramal Pharma Ltd. reported Total Income for Q4FY23 of \u20b9 2,188 Crores\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":144359,"url":"https:\/\/alphastreet.com\/india\/laurus-labs-limited-q4fy23-earnings\/","url_meta":{"origin":145782,"position":4},"title":"Laurus Labs Limited Q4FY23 Earnings","author":"Karan_Singh","date":"April 27, 2023","format":false,"excerpt":"To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active Pharmaceutical Ingredients (API), including intermediates, Generic Finished Dosage Forms (FDF), and Contract Research services. Financial Results: Laurus Labs Ltd. reported Total Income for Q4FY23 of \u20b9 1,382.61 Crores down from\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":145791,"url":"https:\/\/alphastreet.com\/india\/neuland-laboratories-q4fy23-earnings-story\/","url_meta":{"origin":145782,"position":5},"title":"Neuland Laboratories Q4FY23 Earnings Story","author":"Karan_Singh","date":"May 11, 2023","format":false,"excerpt":"Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland Laboratories Ltd. reported Total Income for Q4FY23 of \u20b9 415.1 Crores up from \u20b9 256.5 Crore year on year, a rise of 62%.Total Expenses for Q4FY23 of \u20b9\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/145782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=145782"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/145782\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/138549"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=145782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=145782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=145782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}